Dr Joseph Min Chen, MD | |
Building 1 Coast Guard Island Drive, Alameda, CA 94501 | |
(510) 437-3598 | |
(510) 437-3611 |
Full Name | Dr Joseph Min Chen |
---|---|
Gender | Male |
Speciality | Preventive Medicine - Preventive Medicine/occupational Environmental Medicine |
Location | Building 1 Coast Guard Island Drive, Alameda, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1952388464 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083P0500X | Preventive Medicine - Preventive Medicine/occupational Environmental Medicine | MA55549 (New Jersey) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Joseph Min Chen, MD 371 Anderson Rd, Alameda, CA 94502-7777 Ph: (510) 769-5913 | Dr Joseph Min Chen, MD Building 1 Coast Guard Island Drive, Alameda, CA 94501 Ph: (510) 437-3598 |
News Archive
In a study to be presented Friday, Jan. 27, in the oral concurrent session at 1:15 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, researchers with the Baylor College of Medicine in Houston, Texas, presented the study titled Association between day and month of delivery with maternal-fetal mortality: weekend effect and July phenomenon in current obstetric practice.
A multi-disciplinary panel of blast-related injury experts from eight countries that have recently experienced terrorist attacks examined and discussed their emergency medical response to blast events and identified common issues that could be used by others to enhance preparedness.
The Cancer Institute of New Jersey is one of 50 sites across the nation to offer a clinical trial known as COMET-2 that examines whether the drug cabozantinib is effective in reducing bone pain in patients with prostate cancer that is no longer responsive to hormone therapy and has spread (metastasized) to other parts of the body.
Breast cancer is the most common cancer in women worldwide, but many immunotherapies have had limited success in treating aggressive forms of the disease.
› Verified 5 days ago